2024
Trends in the Prescribing of Buprenorphine for Opioid Use Disorder, 2019-2023
Savitz S, Stevens M, Nath B, D’Onofrio G, Melnick E, Jeffery M. Trends in the Prescribing of Buprenorphine for Opioid Use Disorder, 2019-2023. Mayo Clinic Proceedings Innovations Quality & Outcomes 2024, 8: 308-320. PMID: 38841599, PMCID: PMC11152959, DOI: 10.1016/j.mayocpiqo.2024.04.004.Peer-Reviewed Original ResearchOpioid use disorderTreat alcohol use disorderAlcohol use disorderUse disorderX-waiverMedicare Advantage enrolleesTreat opioid use disorderRate ratiosEvaluate trendsPrescribing of buprenorphineOptumLabs Data WarehouseDaily doseCommercial enrolleesCoronavirus diseasePrescription fillsBuprenorphineDays supplyBuprenorphine prescribingFilling patternBuprenorphine accessImprove buprenorphine accessStudy periodResponse to coronavirus diseasePrescriber typePrescribing
2023
National trends in emergency conditions through the Omicron COVID‐19 wave in commercial and Medicare Advantage enrollees
Stevens M, Melnick E, Savitz S, Jeffery M, Nath B, Janke A. National trends in emergency conditions through the Omicron COVID‐19 wave in commercial and Medicare Advantage enrollees. Journal Of The American College Of Emergency Physicians Open 2023, 4: e13023. PMID: 37576118, PMCID: PMC10423035, DOI: 10.1002/emp2.13023.Peer-Reviewed Original ResearchEmergency care-sensitive conditionsMedicare Advantage enrolleesED visitsVisit ratesPulmonary embolismPandemic waveWave 2Acute cardiovascular conditionsCause ED visitsMyocardial infarction rateED visit ratesEmergency department visitsPre-pandemic ratesCross-sectional analysisPre-pandemic periodInfarction rateCOVID-19 waveDepartment visitsSevere arrhythmiasFemale enrolleesMyocardial infarctionCardiovascular conditionsPercent changeSensitive conditionsEnrollees